Advances in the Development of mRNA Medicines and mRNA Vaccines

Dear Colleagues,

Synthetic mRNA is attracting much attention as a new drug modality, with significant interest in the next applications of mRNA medicines and vaccines. This Special Issue of Pharmaceutics will address new ideas for developing mRNA medicines and vaccines, including mRNA design (e.g., modified nucleotides, self-amplified mRNA), delivery systems (e.g., lipid nanoparticle (LNP), polyplex carrier, injection device), refinements to improve safety, and proof-of-concept studies using animal models. Original research papers or review articles on any of these aspects are welcomed in this Special Issue.

Prof. Dr. Keiji Itaka
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.